CoreWeave, Inc. Class A Common Stock
CRWV
$99.81
-3.82%
CoreWeave is a modern cloud infrastructure company specializing in providing high-performance Nvidia GPU compute capacity optimized for demanding AI training and inference workloads. It operates as a focused, capital-intensive disruptor in the AI infrastructure-as-a-service space, positioning itself as a nimble alternative to hyperscale cloud providers. The current investor narrative is intensely focused on the company's explosive revenue growth fueled by the AI boom, but this is now tempered by concerns over widening losses, surging capital expenditures, and recent disappointing forward guidance, creating a high-risk, high-reward debate around its path to profitability.…
CRWV
CoreWeave, Inc. Class A Common Stock
$99.81
Related headlines
Investment Opinion: Should I buy CRWV Today?
Rating: Hold. The core thesis is that while CoreWeave operates in a supremely attractive secular growth market, its extreme financial risk profile, lack of profitability visibility, and recent guidance disappointment create an unfavorable risk/reward balance at the current valuation, warranting a cautious stance.
Supporting evidence includes a hyper-growth revenue trajectory of 110% YoY and a strong gross margin of 67.6%, which are compelling. However, these are counterbalanced by a deeply negative net margin of -28.7%, an alarming debt-to-equity ratio of 4.54, and a valuation (PS of 6.07x, EV/Sales of 15.29x) that, while compressed, still prices in near-perfect execution. The stock trades 57% below its 52-week high, reflecting significant de-risking, but the 15-analyst average revenue estimate of $71.5 billion seems extraordinarily optimistic given the current scale.
The thesis would upgrade to a Buy if the company demonstrates a clear path to moderating cash burn (e.g., sequential CapEx decline), shows sustained operating margin improvement, or if the stock price falls materially below its current PS ratio trough toward the $70-$80 range, offering a larger margin of safety. It would downgrade to a Sell if quarterly revenue growth decelerates below 50% YoY, if free cash flow burn fails to improve, or if liquidity concerns escalate (current ratio falling further). At present, the stock is fairly valued relative to its immense growth potential but extreme risks, making it suitable only for the most risk-tolerant portion of a portfolio.
Sign up to view all
CRWV 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The growth story is intact but now faces a critical execution phase where managing the balance between growth investment and financial sustainability is paramount. The recent guidance disappointment and stock price reaction have appropriately increased the risk premium. The stance would upgrade to bullish on concrete evidence of operating leverage and reduced cash burn intensity, likely visible in H2 2026 earnings. It would downgrade to bearish on any indication of a financing shortfall or a material slowdown in top-line growth. For now, the high volatility and binary outcome profile suggest waiting for clearer signals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CoreWeave, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $129.75 and implied upside of +30.0% versus the current price.
Average Target
$129.75
15 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
15
covering this stock
Price Range
$80 - $130
Analyst target range
The stock is covered by 15 analysts, and institutional ratings show a predominantly bullish sentiment with recent actions including 'Buy', 'Outperform', and 'Overweight' from firms like Citigroup, Evercore ISI, and Cantor Fitzgerald, though there are notable 'Hold' or 'Neutral' ratings from Truist and Mizuho. The consensus recommendation leans bullish, and analyst estimates project substantial future growth with an average revenue estimate of $71.52 billion and an average EPS estimate of $11.31, implying a dramatic swing to profitability. The wide range between the low revenue estimate of $58.49 billion and the high of $80.46 billion signals high uncertainty and divergent views on the company's near-term growth trajectory and ability to manage costs. The pattern of recent ratings in March 2026 shows reaffirmations of bullish stances post-earnings, indicating maintained institutional support despite the stock's volatility and negative quarterly results.
Bulls vs Bears: CRWV Investment Factors
The investment debate for CoreWeave (CRWV) is a classic high-risk, high-reward tension between explosive top-line growth in a secular megatrend and a deeply concerning path to profitability. The bull case, currently supported by stronger evidence in the form of 110% YoY revenue growth and robust gross margins, hinges on the company successfully scaling into its massive capital investments. The bear case, however, is formidable, centered on a cash burn crisis, deteriorating net margins, and high financial leverage. The single most important tension is the race between revenue scaling and cash burn: if revenue growth can accelerate sufficiently to outpace the capital expenditure burden and deliver operating leverage, the stock could soar. If growth decelerates or financing becomes constrained before profitability is in sight, the downside risk is severe. Currently, the bear side has gained momentum due to the recent guidance disappointment, tilting the near-term evidence towards caution.
Bullish
- Hyper-Growth Revenue at 110% YoY: Q4 2025 revenue of $1.57 billion grew 110.3% year-over-year, demonstrating CoreWeave's powerful capture of surging AI compute demand. This growth rate, while decelerating sequentially, validates its position as a key infrastructure provider in the AI boom.
- Strong Underlying Gross Margin of 67.6%: The company's core service is economically viable, evidenced by a robust Q4 gross margin of 67.6%. This high margin provides a solid foundation for future profitability once operating leverage is achieved and capital expenditure intensity moderates.
- Analyst Consensus Remains Bullish: Despite recent volatility, the analyst consensus leans bullish with 15 covering firms, and recent actions in March 2026 reaffirmed 'Buy' and 'Outperform' ratings. This institutional support suggests confidence in the long-term growth narrative, with average revenue estimates projecting a massive jump to $71.5 billion.
- Valuation Compression to Near-Record Lows: The stock's Price-to-Sales ratio has compressed dramatically from 19.82x to 6.07x, trading near the bottom of its recent valuation band. This significant de-rating, following a -64.84% max drawdown, may present a potential entry point if growth expectations are met.
Bearish
- Widening Losses & Deteriorating Profitability: Net losses are ballooning, with Q4 2025 net income of -$451.7 million representing a net margin of -28.7%, a severe deterioration from -8.1% in Q3. This indicates that surging interest costs and operating expenses are overwhelming strong gross profits.
- Extreme Cash Burn & Financing Dependence: Free cash flow is deeply negative at -$7.25 billion (TTM), driven by massive Q4 capital expenditures of -$4.06 billion. With a weak current ratio of 0.46, the company is entirely dependent on external financing to fund its aggressive, capital-intensive build-out, creating significant liquidity and dilution risk.
- High Leverage with Debt/Equity of 4.54: The balance sheet carries substantial financial risk with a debt-to-equity ratio of 4.54. This high leverage amplifies risks in a rising interest rate environment and constrains financial flexibility, making the company vulnerable to any slowdown in growth or access to capital markets.
- Recent Guidance Disappointment & Momentum Breakdown: The stock is down -9.60% over the past month, starkly underperforming the SPY's +5.6% gain, driven by disappointing Q2 revenue guidance and a wider-than-expected Q1 loss. This signals a breakdown in near-term momentum and raises execution concerns.
CRWV Technical Analysis
The stock is in a volatile but sustained uptrend over the past year, evidenced by a 1-year price change of +63.14%, significantly outperforming the SPY's +25.19% gain. With a current price of $107.3, it is trading at approximately 57% of its 52-week range ($63.8 to $187.0), indicating it has retreated meaningfully from its highs, which may present a potential entry point after a significant correction. Recent momentum has turned sharply negative, with the stock down -9.60% over the past month, starkly contrasting the SPY's +5.6% gain and signaling a significant short-term breakdown in relative strength. This 1-month decline diverges from the positive 3-month (+11.72%) and 6-month (+38.70%) trends, suggesting a potential trend reversal or a deep pullback within the longer-term uptrend, likely driven by the recent disappointing earnings guidance. Key technical support is at the 52-week low of $63.8, while resistance is at the 52-week high of $187.0; a sustained break below the recent lows near $107 could signal a test of deeper support, while reclaiming the $137 level (the recent May high) would be needed to restore bullish momentum. The stock exhibits high volatility, with a maximum drawdown of -64.84% over the period, underscoring its speculative, high-beta nature which demands careful risk management.
Beta
—
—
Max Drawdown
-64.8%
Largest decline past year
52-Week Range
$64-$187
Price range past year
Annual Return
+15.3%
Cumulative gain past year
| Period | CRWV Return | S&P 500 |
|---|---|---|
| 1m | -14.6% | +3.3% |
| 3m | +4.6% | +6.9% |
| 6m | +44.2% | +12.4% |
| 1y | +15.3% | +23.4% |
| ytd | +25.8% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRWV Fundamental Analysis
CoreWeave is exhibiting hyper-growth in revenue, with Q4 2025 revenue of $1.57 billion representing a staggering 110.3% year-over-year increase, continuing a multi-quarter acceleration from $0.98 billion in Q1 2025. This growth is unequivocally driven by surging demand for AI compute, though the most recent quarterly sequential growth from Q3's $1.36 billion was a more moderate 15.2%, which may signal a deceleration in the growth rate. The company is deeply unprofitable on a net income basis, reporting a Q4 net loss of -$451.7 million, which equates to a net margin of -28.7%, a significant deterioration from the -8.1% net margin in Q3. However, it maintains a robust gross margin of 67.6% (Q4 2025), indicating its core service is economically viable, but operating expenses and heavy interest costs are overwhelming profitability. The balance sheet reveals significant financial risk, with a debt-to-equity ratio of 4.54 and a weak current ratio of 0.46, indicating high leverage and potential liquidity constraints. Cash flow is a critical concern, with trailing twelve-month free cash flow deeply negative at -$7.25 billion, driven by massive capital expenditures of -$4.06 billion in Q4 alone to build out infrastructure, meaning the company is entirely dependent on external financing to fund its aggressive growth.
Quarterly Revenue
$1.6B
2025-12
Revenue YoY Growth
+1.10%
YoY Comparison
Gross Margin
+0.67%
Latest Quarter
Free Cash Flow
$-7.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRWV Overvalued?
Given the company's negative net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 6.07x based on the latest quarterly revenue annualized, while the forward PS is not explicitly calculable but implied to be lower given analyst revenue estimates of $71.5 billion for the next period, suggesting the market is pricing in immense future growth. A direct industry average PS is not provided in the data, but the company's EV/Sales of 15.29x indicates the market is assigning a substantial premium for its hyper-growth profile in the AI infrastructure sector. Historically, the stock's own PS ratio has compressed dramatically from 19.82x at the end of Q4 2025 to the current 6.07x, indicating it is trading near the bottom of its recent valuation band. This compression reflects a market reassessment from pricing pure growth to incorporating heightened risks around profitability and cash burn, suggesting the stock may be in a value zone if growth expectations are met, but remains vulnerable if execution falters.
PE
-26.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -155x~-12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on cash burn and leverage. The company reported a staggering TTM free cash flow of -$7.25 billion, with Q4 2024 capital expenditures alone at -$4.06 billion, indicating an insatiable appetite for external capital to fund growth. With a debt-to-equity ratio of 4.54 and a weak current ratio of 0.46, CoreWeave has minimal liquidity cushion and is highly vulnerable to any disruption in debt or equity markets. Furthermore, net losses are widening dramatically, with the Q4 net margin deteriorating to -28.7% from -8.1% the prior quarter, signaling that profitability remains a distant goal despite 110% revenue growth.
Market & Competitive Risks include valuation compression and sector volatility. The stock's EV/Sales of 15.29x, while compressed from its peak, still implies a substantial growth premium that is vulnerable if execution falters or AI hype cycles. As a pure-play AI infrastructure stock with a -9.6% 1-month return against a +5.6% SPY gain, it exhibits high beta and is prone to sharp rotations out of speculative growth names. Competitive risks are omnipresent from hyperscale cloud providers (AWS, Azure, GCP) who are also making massive AI infrastructure investments, potentially pressuring pricing and margins over time.
Worst-Case Scenario involves a 'growth stall and financing crunch.' A combination of slower-than-expected customer adoption, increased competition, and a tightening capital market could lead to a scenario where revenue growth decelerates sharply while cash burn remains high. This could trigger a liquidity crisis, forcing dilutive equity raises or debt restructuring at unfavorable terms. In this adverse scenario, the stock could realistically retest its 52-week low of $63.8, representing a downside of approximately -41% from the current price of $107.3. The historical maximum drawdown of -64.84% provides a stark reminder of the potential volatility.
FAQ
The key risks are, in order of severity: 1) Financial/Liquidity Risk: The company is burning cash at an alarming rate (-$7.25B TTM FCF) and has a weak current ratio (0.46), making it entirely dependent on external financing. 2) Profitability Risk: Net losses are widening, with the Q4 2025 net margin at -28.7%, indicating no near-term path to profits. 3) Leverage Risk: A debt-to-equity ratio of 4.54 amplifies all other risks and increases sensitivity to interest rates. 4) Execution & Competitive Risk: Any slowdown in the sequential revenue growth rate (already decelerated to 15.2% QoQ) or increased competition from hyperscalers could derail the growth narrative and valuation.
The 12-month forecast is highly bifurcated, with three distinct scenarios. The Base Case (50% probability) sees the stock trading between $100 and $135 as growth continues but profitability concerns linger. The Bull Case (25% probability), driven by successful execution and multiple expansion, targets $160 to $187 (near its 52-week high). The Bear Case (25% probability), triggered by a growth stall or financing crunch, could see the stock fall to between $63.8 (its 52-week low) and $90. The most likely outcome is the Base Case, where the stock remains volatile but range-bound as the market awaits clearer signs of a path to profitability.
CRWV's valuation is highly subjective and contingent on future growth. Based on a trailing Price-to-Sales ratio of 6.07x and an EV/Sales of 15.29x, the market is pricing in immense future growth but has already significantly de-rated the stock from a PS of 19.82x. Relative to its own history, it is trading near the bottom of its valuation band, which could be seen as undervalued if growth meets expectations. However, given the lack of profits and high financial risk, the current multiples are not cheap. The valuation is fair relative to the extreme growth potential but fails to provide a margin of safety against the substantial execution risks.
CRWV is a high-risk, high-potential stock that is not a good buy for most conservative or income-oriented investors. For aggressive growth investors with a high risk tolerance and a long-term horizon, the current price, which is 57% off its 52-week high, may present a speculative entry point. The bullish case rests on the company achieving its analyst-projected revenue of over $71 billion and eventually turning its strong gross margins into net profits. However, the severe risks—including a -$7.25 billion TTM free cash flow burn, debt-to-equity of 4.54, and recent guidance disappointment—mean it should only constitute a small, speculative portion of a portfolio.
CRWV is categorically unsuitable for short-term trading or investment due to its extreme volatility (evidenced by a -64.84% max drawdown) and high sensitivity to quarterly earnings and guidance. It is a long-term, speculative growth investment with a minimum suggested holding period of 3-5 years. This timeframe is necessary to see if the company can scale its revenue to the tens of billions projected, achieve operating leverage, and ultimately generate positive free cash flow. Investors must be prepared for significant price swings and have the patience to wait through multiple earnings cycles.